Gut Reset: When the Body Has to Restart
Why chronic gut problems are rarely where you first look, and what a real reset really means
Chronic gut problems are among the most stubborn pictures I meet in practice. Bloating, alternating stool, exhaustion. The diagnostics run, the therapies run, and a few weeks later everything is back.
The case that shaped my perspective the most came from my own family. It showed me that with stubborn gut problems I have to think about the environment, not just the gut. The details do not belong in a public text. What I took from it does: mold and its mycotoxins can create an inflammatory load against which a purely gut-directed therapy can achieve little, as long as the source remains.
That experience changed my perspective. Since then I look earlier at the environment and at the whole system with stubborn gut problems, not only at the gut itself. And it is the reason why Gut Reset is one of my four specialty areas at ViveCura, alongside ketamine therapy, mold treatment, and heavy-metal detoxification.
The gut: far more than digestion
Before we talk about problems and solutions, a moment of awe is worthwhile. The human gut is one of the most complex organ systems that evolution has produced, and we have underestimated it for far too long.
The enteric nervous system of the gut contains as many neurons as the spinal cord. It communicates via the vagus nerve, the long nerve that connects heart, lungs, and abdominal organs, bidirectionally with the brain. The larger share of signals travels from the gut to the brain, not the other way around. Exact percentages vary between sources. That means a disturbed gut can influence mood, cognitive performance, anxiety, and pain perception.
The vagus nerve, the nervous system of the gut
The vagus nerve is the most important hub between gut and brain. It regulates gut motility (the transport movement of intestinal contents), modulates the immune response, and coordinates the release of digestive juices. Chronic inflammation in the gut, for example through mycotoxins, bacterial toxins, or dysbiosis, can damage this nerve directly via cytokines. The result: slowed motility, chronic constipation, and a vicious circle that sustains itself.
Transcutaneous vagus nerve stimulation (tVNS) showed improvements in functional dyspepsia, gastroparesis, IBS, and chronic inflammatory bowel diseases in several clinical studies, with better gut motility and an increase in protective bacteria. The trials are small and the evidence base is still limited.
Yin, 2025, Journal of Translational Gastroenterology · Liu et al., 2024, Neurobiology of DiseaseGut bacteria even communicate directly with the brain via the vagus nerve: certain Lactobacillus strains produce GABA, the same neurotransmitter that dampens anxiety and regulates sleep in the brain. In animal models this signalling pathway was interrupted after the vagus nerve was cut. That speaks for the connection being real. In humans it has not been shown that directly yet.
The myth that “fiber is always good”
Hardly any piece of advice sounds more obvious: “Eat more fiber for a healthy gut.” This sentence is correct in a healthy gut. In a disturbed gut, it can considerably worsen the situation.
“More fiber equals better gut health.” This simplification ignores that fermentable fiber in SIBO feeds exactly what you want to eliminate: the misplaced bacteria in the small intestine.
FODMAPs, the problem with short-chain sugars
FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols) are a category of short-chain carbohydrates that are poorly absorbed in the small intestine and rapidly fermented in the large intestine. The problem: in SIBO, this fermentation already happens in the small intestine, with gas production, bloating, abdominal pain, and diarrhea as immediate consequences.
Even resistant starch, normally a high-quality fiber, can trigger symptoms in IBS patients. In a pilot RCT, every tested dose of resistant starch (10 to 20 g/day) significantly intensified bloating in IBS patients. The individual microbiome composition decisively determines how someone reacts to specific fibers.
Cuffe et al. compared 28 randomized trials with 2,338 IBS patients. A starch- and sucrose-reduced diet came out first arithmetically (RR 0.41), but on the basis of only two trials. Low-FODMAP came fourth and was the only diet that outperformed standard advice for bloating. The authors rate the confidence of most comparisons as low or very low and see the broadest evidence base for a low-FODMAP diet.
Cuffe et al., 2025, Lancet Gastroenterology & Hepatology, DOI 10.1016/S2468-1253(25)00054-8Cox et al. (RCT, n=52, 4 weeks) found lower Bifidobacterium adolescentis, B. longum, and Faecalibacterium prausnitzii under a low-FODMAP diet, with unchanged microbiome diversity and unchanged inflammatory markers. The authors rate the four weeks as safe and effective. For me that is the reason to use low-FODMAP for a limited time and not permanently.
Cox et al., 2020, Gastroenterology, DOI 10.1053/j.gastro.2019.09.024My therapeutic approach: low-FODMAP or SCD (Specific Carbohydrate Diet) are used temporarily and in a targeted way, never as a permanent way of eating without addressing the root cause. Dietary intervention has to follow the diagnostic findings, not the other way around.
Irritable bowel, an honest framing
The diagnosis of irritable bowel syndrome (IBS) affects 10 to 15% of the population worldwide. It is the most common gastroenterological diagnosis at all, and strictly speaking it describes only symptoms: recurring abdominal pain associated with stool changes, without an organically explainable finding.
This diagnosis is not wrong. But it is not a cause-based diagnosis. It says: “Your gut does not function normally, and we do not know why.” That is medically honest, but therapeutically incomplete.
“Irritable bowel” is not a destination, it is a starting point. For me, the actual work begins here: what is really behind it?
Shukri Jarmoukli, ViveCura BerlinThe functional-medicine perspective views irritable bowel symptoms as signals of a system that is out of balance. And in my clinical experience, this imbalance almost always has one or more identifiable causes: SIBO, fungal overgrowth, parasites, mold burden, food intolerances, histamine problems, low stomach acid, toxic burden, or psychological stressors.
Conventional treatment of irritable bowel is important and often brings quick relief: antispasmodics, fiber supplements, low-dose antidepressants. A functional perspective additionally asks: why does the gut behave this way? Which infections, toxins, nutritional deficits, or psychosomatic patterns might play a part? The two can complement each other well.
The diagnostic universe of gut pathology
The world of gut disorders is complex. What you will read here is not a complete list, it is an honest overview of the diagnoses that I see in my daily practice, that are often overlooked, and that taken together explain why so many people travel from doctor to doctor for years without finding help.
Bacterial conditions
SIBO, small intestinal bacterial overgrowth
Normal gut bacteria settle in the small intestine, where they do not belong. They ferment carbohydrates already in the small intestine and produce gases (hydrogen, methane, hydrogen sulfide). Symptoms: bloating soon after eating, pressure, alternating stool, nutrient deficiencies. Prevalence in IBS patients: 4 to 78% depending on the study. The variance reflects diagnostic differences, not chance.
IMO, methanogen overgrowth
Methanogens are archaea, not bacteria, that produce methane. Methane can slow gut transit time and correlates with constipation-dominant IBS (IBS-C). Breath test cutoff: at least 10 ppm methane. With a methane-dominant overgrowth, different medications come into question than with classic SIBO. Which ones, and whether they fit you, we clarify in consultation. That belongs in medical hands.
General dysbiosis
Quantitative or qualitative imbalance of the gut microbiota. Meta-analysis of 23 studies (n=1,340): IBS patients have significantly lower Lactobacillus levels (−0.57 log CFU/g), lower Bifidobacterium levels (−1.04 log CFU/g), and higher E. coli abundance (+0.60 log CFU/g) compared to healthy individuals.
Specific toxic strains
Some gut bacteria, for example Klebsiella pneumoniae or Proteus mirabilis, can form metabolites that may burden the gut wall, tax the liver, and set off inflammatory responses. For Klebsiella it is also discussed that certain prebiotics (FOS) may favour its growth. Uncritical prebiotic intake can therefore worsen the situation.
Fungal and parasitic conditions
SIFO / FIBO, small intestinal fungal overgrowth
Small Intestinal Fungal Overgrowth: fungi (mostly Candida species) colonize the small intestine. Two clinical studies showed a prevalence of 25 to 26% among patients with unexplained GI symptoms. Candida can form candidalysin, an exotoxin that may attack the gut barrier. There is no validated non-invasive diagnostic test, stool culture or PCR is necessary.
Candida overgrowth in the colon
Candida albicans can, under certain conditions (prior antibiotics, carbohydrate-rich diet, immunosuppression), overgrow the colon. In cell models an increase in gut permeability has been observed. Specific dietary adjustments (sugar reduction, antifungal therapy) are necessary, but blind without diagnostics.
Parasite infection
In my experience, parasitic gut infections are easily missed in routine diagnostics. Standard stool samples can come back falsely negative. PCR-based stool tests and repeated sampling can raise the detection rate. Which pathogens are tested for, and what a treatment looks like, belongs in a medical consultation and not in a public text.
Mycotoxins, mold poisons in the gut
Mold toxins (deoxynivalenol, zearalenone, aflatoxin B1, ochratoxin A) can damage tight-junction proteins (ZO-1, claudin-1, occludin), increase gut permeability, alter the microbiome, and affect vagal function via inflammatory messengers. So far this has been described mainly in cell and animal models. How strongly it applies to humans is not conclusively established. Possible sources: food, mold burden in the living environment.
Immunological and barrier disorders
Leaky gut, increased gut permeability
Disturbed tight junctions allow large molecules (undigested protein particles, bacterial fragments, LPS endotoxins) to cross into the bloodstream. The immune response to this can generate antibodies against these particles. Food reactions, systemic inflammation, and a contribution to autoimmune processes are discussed. Zonulin, the peptide that opens tight junctions, can be upregulated by gliadin (wheat), SIBO, and mycotoxins.
Histamine intolerance
Diamine oxidase (DAO), the enzyme that breaks down histamine in the gut epithelium, is reduced in some people genetically or by acquisition. Histamine-rich foods (aged cheese, red wine, canned fish, fermented foods, chocolate) then trigger systemic reactions: headaches, flushing, palpitations, nasal congestion, diarrhea. The symptoms vary widely and are therefore often misdiagnosed.
MCAS, mast cell activation syndrome
Mast cells link the immune and the nervous system. In MCAS they react over-sensitively to triggers (foods, smells, light, heat, stress) and release histamine and more than 200 other mediators. Unlike classical allergies, the reactions are inconsistent, sometimes strong, sometimes not. Possible triggers discussed include mold burden, certain bacterial infections, and viral illnesses. The data on this are thin. I observe clinically that symptoms can improve when a possible burden in the environment is addressed.
Food intolerances
Beyond the well-known IgE-mediated immediate allergy, there are delayed reactions (IgG-mediated, 2 to 72 hours after exposure), enzymatic intolerances (lactase, fructase deficiency), FODMAP sensitivity, and gluten/gliadin intolerance without celiac disease. Gliadin can increase gut permeability via zonulin release, and this is discussed for people without celiac disease as well. After contact with gliadin the gut wall may need some hours to recover. Exact time figures cannot be derived from that.
Functional and organic disorders
Hypochlorhydria, low stomach acid
Too little stomach acid is, paradoxically, a frequent cause of heartburn, the very symptom for which PPIs (proton pump inhibitors) are reflexively prescribed. Without enough HCl, proteins are incompletely digested, minerals (magnesium, zinc, iron) are poorly absorbed, and the stomach loses its barrier function against bacteria and fungi. Long-term PPI use can lower stomach acid so far that the barrier function suffers, and it is discussed in connection with a raised SIBO risk. Please never stop a PPI on your own. There are situations in which it is necessary, and abrupt discontinuation can make symptoms worse. Talk to the doctor who prescribed it first.
Gallbladder dysfunction
Bile is not only needed for fat digestion, it is the body’s most important elimination route for fat-soluble toxins (including mycotoxins). It produces secretory IgA (sIgA) and stimulates the innate immune response in the gut. Under inflammation, bile secretion is compromised. Symptoms: poor fat digestion, bloating after fatty meals, fatty stools, deficiency of fat-soluble vitamins (A, D, E, K).
Enzyme insufficiency, too few digestive enzymes
The pancreas and the small-intestinal mucosa produce enzymes for proteins (proteases), fats (lipases), and carbohydrates (amylases). Stress, inflammation, alcohol, aging, or chronic illness reduce this production. Undigested proteins that reach the colon are fermented by proteolytic bacteria, with toxic metabolites as a result. Visible in stool tests as undigested food residues or elevated fecal fat.
Ileocecal valve and vagal tone
The ileocecal valve separates small and large intestine and prevents backflow of colonic bacteria into the small intestine. With low vagal tone it may not close fully. This is discussed as one possible mechanism for SIBO relapses, but it is not well established. Test: pressure tenderness about 5 cm right of the navel. Therapy: vagus stimulation, acetylcholine support.
Why a gut reset is a system reset
Here lies the decisive difference between symptomatic therapy and a real gut reset: the gut is not an isolated organ. It is closely networked with the hormonal system, the immune system, the central nervous system, and the detoxification system. What damages the gut rarely comes from the gut alone.
Toxins as underestimated gut destabilizers
Mycotoxins (mold poisons from food or the living environment) show, in in-vitro and animal studies, direct damage to the gut barrier at the molecular level: reduction of tight-junction proteins, activation of the NLRP3 inflammasome, induction of pyroptosis (cell death). At the same time, they disturb the gut microbiome, with depletion of protective Lactobacillus strains and promotion of pathogenic species.
In a cell model using intestinal organoids of animal origin (chicken), deoxynivalenol damaged the cell junctions and increased permeability. In humans this has not been shown that way yet. It is a hint at a possible mechanism, no more than that.
Kang & Lee, 2024, Journal of Animal Science and Biotechnology, DOI 10.1186/s40104-023-00976-4For glyphosate, the most widely used herbicide worldwide, there are indications from cell and animal models that it can alter the gut microbiome. A systematic review from 2024 summarizes this. What it means for humans at everyday doses is still open. I mention it as a possible contributor, not as an established cause.
Psyche, trauma, and the gut-brain axis
Chronic stress can put a considerable load on the gut. Cortisol can increase gut permeability, shift the balance of Lactobacilli and Bifidobacteria, and activate mast cells in gut tissue. Adverse childhood experiences (ACEs) are associated with a higher risk of functional gut disorders in adulthood, via autonomic dysregulation, altered HPA-axis reactivity, and epigenetic changes.
Black et al. (2020, Gut, 41 RCTs, 4,072 patients) found the largest evidence base for gut-directed hypnotherapy (RR 0.67) and cognitive behavioral therapy (RR 0.61 to 0.62). None of the methods was superior to another. The authors point to a high risk of bias, so the effect is more likely overestimated than underestimated.
Black et al., 2020, Gut, DOI 10.1136/gutjnl-2020-321191The gut microbiome forms neurotransmitter precursors and can influence serotonin availability via the tryptophan-kynurenine pathway as well as GABA formation. Dysbiosis is therefore probably not only a digestive topic, it also concerns the nervous system.
As long as toxins are present, stress destabilizes the system, or the vagus nerve does not function, every purely diet-based or antibiotic-based gut therapy will only work temporarily. Lasting success needs a system understanding.
Shukri Jarmoukli, ViveCura BerlinDiagnostics, what I actually test
My diagnostic approach in gut problems is comprehensive, and is always guided by the individual history. Not every test is necessary for every patient. But without complete diagnostics, I work blind. Here is what I use, and why.
Stool diagnostics
What a good stool test shows
- PCR dysbiosis panel: quantitative analysis of Lactobacilli, Bifidobacteria, E. coli (subtypes), Klebsiella, Clostridium, Proteus, Bacteroides, Faecalibacterium prausnitzii (the most important butyrate-producing species)
- Toxic fungi: Candida albicans and other Candida species, molds in the gut lumen (often overlooked)
- Parasites: when a parasitic cause is suspected, I use modern PCR-based stool diagnostics instead of classical microscopy, because it can be more sensitive. Which pathogens are tested for depends on your history
- Fiber-degrading microbiota: Bifidobacterium adolescentis, Ruminococcus bromii, key bacteria for butyrate production and mucosal nutrition
- Neuroactive microbiota: Lactobacillus plantarum, Bifidobacterium adolescentis as GABA producers
- Stool pH: target range 5.5 to 6.5 (too alkaline = excess proteolytic fermentation)
- Elastase-1: marker for exocrine pancreatic function and enzyme production
- Fecal calprotectin: inflammation marker in the gut, differentiates inflammatory from non-inflammatory disease
- Secretory IgA (sIgA): local immune defense of the gut, often exhausted under chronic load
- Alpha-1 antitrypsin: marker for protein loss across the gut wall (protein-losing enteropathy)
Blood diagnostics
Blood tests with direct relevance to the gut
- Inflammation markers: CRP (high-sensitivity), IL-6, TNF-alpha (when systemic inflammation is suspected)
- Nutrient status: vitamin B12, folate, vitamin D, zinc, magnesium, ferritin/iron. All can be reduced by malabsorption
- Liver values: AST, ALT, GGT, alkaline phosphatase. The liver is the main detoxification organ and is co-affected in chronic dysbiosis
- Thyroid: TSH, fT3, fT4. Hypothyroidism slows gut motility directly
- Fasting insulin, blood sugar, HbA1c: insulin resistance amplifies fungal overgrowth and chronic inflammation
- IgE (total and specific): when true IgE allergy is suspected (not to be confused with IgG-based tests, which lack clinical validity)
- Histamine, diamine oxidase (DAO): when histamine intolerance is suspected
- Zonulin: as an orienting marker for gut permeability (limitation: commercially available ELISAs may be measuring properdin rather than true zonulin, results are interpreted in context)
- Differential blood count: eosinophilia as a hint at parasites or allergic reactions
Breath tests and specialized diagnostics
Complementary diagnostics
- SIBO breath test (H₂/CH₄): indicative, but with known limitations. False-negative results are common. A negative test does not rule out SIBO; clinical picture and response to therapy are decisive
- Lactose breath test: quantitative diagnostic for lactose intolerance
- Fructose breath test: for fructose malabsorption
- Organic acids in urine: D-arabinitol is discussed as an indicative marker for Candida burden. Its informative value is limited, so I read it only within the overall clinical picture
- The mold question: there is no generally accepted laboratory diagnostic for mold burden. The German S2k guideline on medical clinical diagnostics after indoor mold exposure views the lymphocyte transformation test and mycotoxin measurements in urine critically for this indication and does not recommend them. I therefore use such tests only as an addition, and only when history and living situation suggest a suspicion. Beforehand I discuss openly what they can and cannot deliver. The most important step remains clarifying the living environment itself
- Elimination diet: still the gold standard for food intolerances. Complete elimination of suspected foods for 7 to 10 days, then systematic reintroduction
My protocol, integrative, individual, three-phase
No patient is like another. That is why there is no one-size-fits-all protocol with me. What there is, is a systematic frame that is applied individually to each patient.
Comprehensive history
Medical history, prior conditions, medications, previous therapies, living environment, stress levels, mental history, eating habits, travel history. I listen, really.
Targeted diagnostics
Based on history: stool diagnostics, blood panel, breath tests, and where indicated, specialized diagnostics for mold, toxins, hormonal axis. Tests follow the clinical picture, not the protocol.
Individual therapy plan
Depending on findings: dietary adjustment, supplements, antimicrobial therapy, detoxification strategies, psychotherapy referral, vagus stimulation. All coordinated and timed in stages.
Dietary strategies, the right tool at the right time
Dietary therapy in a gut reset follows no ideology. It follows the findings. The same way of eating that can relieve the gut in one person can deepen dysbiosis in another. Here are the most important strategies I use:
Paleo Autoimmune Protocol (AIP)
Leaves out grains, legumes, nightshades, eggs, and dairy, all potential immune activators. A small open study with 15 IBD patients showed an improvement in symptoms and, in 6 of 7 people re-examined, a better endoscopic picture. The inflammatory marker calprotectin fell from 471 to 112, without reaching statistical significance (p = 0.12). Without a control group this is a hint, not proof.
SCD plus low-FODMAP (SIBO-specific)
The Specific Carbohydrate Diet combined with low-FODMAP is often used in SIBO. It reduces fermentable carbohydrates that can nourish SIBO bacteria. The goal is to withdraw substrate from the bacteria without harming host cells. Good randomized trials specifically on this combination are lacking so far. Here I rely on the mechanism and on clinical experience.
Low-histamine diet
For histamine intolerance or MCAS: elimination of histamine-rich foods (aged cheese, red wine, fermented foods, leftovers, canned goods, smoked meat). Also account for DAO activators: vitamin B6, vitamin C, copper, calcium. At the same time, avoid DAO inhibitors: alcohol, certain medications (metamizole, metoclopramide).
Anti-Candida / low-fungal eating
Sugar restriction, elimination of yeasts and mold-affine foods (peanuts, pistachios, fermented foods), general carbohydrate reduction. Biologically plausible, since Candida is glucose-dependent. Whether the combination with antifungal therapy adds more than the dietary adjustment alone is not well studied.
Ketogenic / low-carb approaches
Beta-hydroxybutyrate (BHB), the main ketone body, is probably more than just fuel. In cell and animal models it can upregulate claudin-1, inhibit HDAC enzymes, and support the self-renewal of intestinal stem cells. In humans this has not been established that way. The approach is discussed mainly in metabolic endotoxemia and in insulin-resistance-associated gut inflammation.
Elemental diet (short-term, SIBO)
Predigested amino acids, simple sugars, MCT fats, largely absorbed in the proximal small intestine, little substrate for bacteria. In a retrospective analysis without a control group (Pimentel et al. 2004, n=93), the breath test was negative in 80% after 15 days and in 85% after 21 days. The endpoint was the breath test, not freedom from symptoms. It is demanding to follow and belongs under medical supervision.
Sugar reduction as a therapeutic principle
Refined sugar can favour Candida, unfavourable bacteria, and inflammatory processes. The strategy is not lifelong sugar abstinence, but targeted, time-limited restriction during the active treatment phase, combined with eating patterns that stabilize blood sugar (low glycemic index, sufficient fat and protein, regular fasting intervals).
Supplements and infusions, what I actually use
Supplements are not a single solution, they are part of a coordinated plan. Used wrongly, they can do harm: prebiotics in Klebsiella overgrowth feed the pathogen; glutathione during active mold burden can trigger a Herxheimer reaction; methylation substrates (B12, folate) can worsen symptoms during an active CDR (Cellular Danger Response). That is why supplements always follow the diagnostics.
Gut barrier and microbiota rebuild
Building blocks I use depending on findings
- L-glutamine: an important nutrient of the gut cells, used according to findings
- Probiotics in spore form: can survive the stomach environment better than other preparations. With pronounced immune deficiency I do not use them
- Saccharomyces boulardii: a yeast preparation used depending on findings. With pronounced immune deficiency and with an indwelling central venous catheter I avoid it
- Zinc: among other things involved in the normal function of the immune system. I use it when a deficiency is documented
- Butyrate or tributyrin: a short-chain fatty acid, discussed as an energy source for the gut mucosa
- Colostrum: contains immunoglobulins and growth factors. Not suitable with cow's milk protein allergy
Antimicrobial strategy (herbal)
Herbal bitter and spice compounds
- Oregano oil (carvacrol), berberine, allicin from garlic extract, and olive leaf extract are used depending on findings. The evidence base is limited, so I decide individually and for a limited period.
- Berberine and quercetin can affect the breakdown of other medications via CYP3A4 and P-glycoprotein. Berberine is not an option in pregnancy and while breastfeeding.
- Herbal preparations are not a harmless extra either. Please do not take them on your own if you take medication regularly.
Chedid et al. (2014, not randomized, n=104): 46% negative breath tests under herbal therapy versus 34% under the antibiotic. The difference was not statistically significant (p = 0.24). The data suggest that herbal combinations can be a serious option. That is not proof of superiority.
Chedid et al., 2014, Global Advances in Health and Medicine, DOI 10.7453/gahmj.2014.019Digestive support
Enzyme and acid substitution
- Betaine HCl with pepsin: whether there is too little stomach acid is something I check medically, not by self-experiment. Betaine HCl can do harm with existing gastritis, an ulcer, reflux, or under anti-inflammatory painkillers and cortisone, and therefore belongs only in supervised use
- Full-spectrum digestive enzymes (lipase, amylase, protease, lactase): support breakdown in enzyme insufficiency
- Bile support (TUDCA, milk thistle, bitters, phosphatidylcholine): can support bile flow and the elimination of fat-soluble substances. With gallstones or a bile duct obstruction not without medical clarification
- Herbal combination preparations to stimulate gut movement: they can relieve symptoms. As with any medicine there are side effects and interactions, and for individual preparations liver reactions have been described. That is why I discuss their use individually
- Prescription options: in treatment-resistant courses there are additional prescription-only medications. Whether one of them is an option for you is something we decide individually in consultation, not through an article
Infusion therapy, when oral absorption is limited
In pronounced malabsorption, deficiency states, or chronic inflammatory load, I offer targeted IV nutrient infusions. Intravenous delivery can bypass a disturbed gut barrier. Whether it makes sense I decide according to findings and clinical picture. Used then, among others, are:
IV options in a gut reset
- Vitamin C (high-dose): antioxidant and immune-modulating, and involved in collagen synthesis. As an infusion I use it only after prior clarification. Before a first high dose I check kidney function and a possible G6PD deficiency, because both can lead to serious reactions, among them haemolysis and an oxalate load on the kidney. With a tendency to kidney stones I weigh this particularly carefully
- Magnesium: when a deficiency is documented. It can influence gut motility and nervous-system regulation. With impaired kidney function or cardiac arrhythmia I check particularly carefully beforehand
- B-vitamin complex: especially B12 (nerves, methylation) and B5 (bile acid synthesis), critical after phases of malabsorption
- Glutathione: only when root causes have already been addressed. With active mold burden, glutathione can mobilize toxins faster than they can be cleared (with temporary symptom worsening)
- Phosphatidylcholine: cell membrane repair, particularly in neurotoxic burden and disturbed fatty acid status
- Zinc, selenium, trace elements: involved in the normal function of the immune system and in the body’s own detoxification enzymes. I use them when a deficiency is documented, because overdosing can itself do harm
Histamine intolerance and MCAS: mast cell stabilization
Stepped therapeutic plan
- Quercetin: used as a mast cell stabilizer. It can affect the breakdown of other medications, so I set dose and duration individually, especially if you take medication regularly. I explicitly do not recommend titrating it up on your own
- DAO supplement: histamine-degrading enzyme as a capsule before meals, supportive, no replacement for dietary measures
- Antihistamines: there are pharmacological options that can block the histamine pathway. Choice, dosing, and sequence belong in medical hands and are discussed individually
- Consider the root cause: I observe clinically that symptoms can improve markedly in some people when a possible burden in the environment is addressed. Studies on this are largely lacking. I am describing an observation here, not an established effect
Psychotherapy and vagus stimulation as part of the protocol
This is not a nice-to-have. It is a medical necessity. The gut-brain axis is bidirectional, and as long as the nervous system stays in a chronic stress tone, the gut also stays in a state that can make recovery harder.
Gut-directed hypnotherapy and behavioural therapy
Gut-directed hypnotherapy is not alternative medicine. Together with cognitive behavioural therapy it belongs to the psychological methods with the broadest evidence base in IBS, with data from 41 randomized controlled trials (4,072 patients). Neither method was superior to another in the analysis, and the authors point to a high risk of bias. Imaging work suggests that hypnotherapy can influence visceral pain processing. In studies, six sessions showed outcomes similar to twelve. Staying with it seems to matter more than duration.
Vagus stimulation, practical exercises
What activates the vagus nerve
- Slow, deep breathing (4-7-8 method): measurably increases respiratory sinus arrhythmia and vagal tone
- Humming, singing, gargling: directly activates vagus afferents via the laryngeal area. Described by Dr. Datis Kharrazian as the simplest daily vagus exercise
- Cold exposure to face and neck: the dive reflex can activate the vagus. Begin carefully and slowly. With heart disease, cardiac arrhythmia, or high blood pressure please clarify this medically beforehand
- Meditation, yoga, tai chi: reduce cortisol, improve HRV (heart rate variability) as a marker of vagal tone
- Chewing (thoroughly, slowly): stimulates saliva production and parasympathetic preparation for digestion
In patients with strongly weakened gut motility or a diagnosed ileocecal valve dysfunction, I combine vagus exercises with acetylcholine-supporting supplements (choline complex), since acetylcholine is the decisive neurotransmitter for vagal signaling and gut motility.
Chronic gut problems that do not respond to any therapy so far have, in my experience, almost always one of three backgrounds: an undetected toxic burden (mycotoxins, heavy metals, glyphosate), a persistent infection that maintains the cellular danger response (CDR), or a chronically dysregulated nervous system that can repeatedly undercut the recovery of the gut. Mostly it is combinations of all three. That is my clinical observation, not a statement from studies. An integrative plan should keep all of it in mind.
Other conditions in overview
The clinical picture of gut medicine is broader than SIBO and Candida. Here are further connections that I see in practice and that can easily be overlooked in everyday care:
Metabolic endotoxemia
Bacterial LPS endotoxins cross a damaged gut barrier into the bloodstream. Discussed as consequences are low-grade systemic inflammation, insulin resistance, weight gain, cognitive disturbances, and a raised cardiovascular risk. Diagnostically: high-sensitivity CRP, fasting insulin, clinical picture.
Gut-brain axis disorders
For depression, anxiety, brain fog, and fatigue there are connections with the microbiome that are currently under intensive study. They are connections, not a proven cause. Discussed are an altered availability of serotonin precursors and pro-inflammatory messengers that can act on the brain. A gut therapy does not replace psychiatric or psychotherapeutic treatment, it can complement it. Please do not stop prescribed medication on your own. If you are burdened by thoughts of not wanting to live any more, please get help immediately, for example from the German helpline Telefonseelsorge at 0800 111 0 111 or via the emergency number 112.
Crohn’s disease, ulcerative colitis
Chronic inflammatory bowel diseases with described microbiome imbalances, disturbed barrier function, and immunological overactivation. In Crohn’s disease and ulcerative colitis the specialist baseline therapy is the foundation and stays that way. Complementary approaches such as a targeted dietary adjustment can additionally influence the course favourably. Please never reduce or end your prescribed therapy without your gastroenterologist.
Estrogen dominance and the gut
The gut microbiome contains the so-called “estrobolome,” bacterial species that metabolize estrogen. Dysbiosis can shift estrogen levels, may favour estrogen dominance, and can amplify the histamine topic, because estrogen can activate mast cells. An interaction that is easily overlooked.
SIBO-associated hypoglycemia
Bacteria in the small intestine consume carbohydrates before absorption, which can produce paradoxical reactive hypoglycemia. Symptoms: fatigue, palpitations, anxiety, and memory gaps when nothing has been eaten for a longer time.
Oxalate sensitivity
Some patients react particularly sensitively to oxalate-rich foods (kale, spinach, beets, almonds). For oxalates it is discussed that they may favour inflammatory processes and can form crystals in kidney tissue. Often unrecognized in therapy-refractory joint pain, vulvodynia, neuropathy.
What this case taught me
The most intensive continuing education of my life was not a congress. It was a long phase of failing with a gut that responded lastingly to nothing. Not because of the successes, but because of that phase, I learned the most.
We treated what there was to treat. The findings improved briefly, then tipped back. That was the moment when I realized: we are working on symptoms, but we have not yet found the cause.
The trail led into the living environment. Mold and its mycotoxins can create an inflammatory load in the whole system that repeatedly undercuts a local therapeutic approach in the gut. Only once the source of the burden had been addressed could the situation stabilize. I cannot derive causality from that. I am describing a temporal association.
When a gut does not respond lastingly to any therapy, rethink the basic assumptions. Do not ask: “Which antibiotic or probiotic protocol have we not yet tried?” Ask: “What could be keeping the system in an inflammatory state?” Mycotoxins, heavy metals, persistent infections, chronic stress. These factors can repeatedly undercut a treatment attempt in the gut.
This is the reason mold treatment is one of my four specialty areas, right next to Gut Reset. In my practice the two are often connected. What I can offer is a view that considers gut, environment, nervous system, and metabolism together, instead of only one section.
Could a gut reset make sense for you? Help with self-assessment.
What follows is not a diagnosis. It is an honest invitation to pause and observe. Gut problems rarely show clear-cut patterns. They disguise themselves as exhaustion, hormonal disturbance, brain fog, mood instability. And because no single symptom points unambiguously at the gut, people often look everywhere except there.
Go through these questions calmly. Count silently how many points apply to you. The interpretation is at the end.
Area 1: digestion and abdomen
How familiar do these complaints sound?- Bloating or a visibly distended abdomen, especially soon after eating or in the afternoon and evening
- Abdominal pain or cramps that come and go, without imaging finding a cause
- Alternating stool: sometimes constipation, sometimes diarrhea, sometimes both alternating within a few days
- Urge or pressure soon after eating, as if the gut were reacting immediately
- Heartburn, acidic burping, or a persistent pressure in the upper abdomen, perhaps even with chronic PPI use
- Food intolerances that have expanded: things that used to be no problem you no longer tolerate
- Nausea, fullness, or the sense of digesting poorly, especially after meals high in fat or protein
Area 2: systemic and neurological symptoms
The gut often shows up far from the abdomen- Chronic exhaustion that sleep and rest do not really lift. Already tired in the morning.
- Brain fog: concentration problems, word-finding difficulty, the sense of being mentally behind frosted glass
- Mood swings, irritability, or anxiety without an explainable outer trigger. The gut communicates with the brain via nerves and messengers and can influence mood that way.
- Sleep problems, especially trouble falling asleep or staying asleep. The gut directly influences sleep via the melatonin-serotonin axis.
- Hormonal imbalances: cycle disturbances, severe PMS, estrogen dominance, or unexplained weight gain. The microbiome metabolizes estrogen directly.
- Headaches or migraines that have no neurological finding and cluster after meals or at certain times of day
Area 3: skin, immune system, joints
Inner inflammation shows on the outside- Eczema, rashes, acne, or rosacea that has slowly worsened or does not respond lastingly to skin therapy
- Frequent infections or an over-long recovery time from colds. The immune system sits 80% in the gut.
- New allergies or intolerances in adulthood that were not present before
- Diffuse joint or muscle pain without an orthopedic finding, that wanders and cannot be located
- An autoimmune disease in your history: for many autoimmune conditions an involvement of the gut is discussed, among them Hashimoto, psoriasis, and inflammatory bowel disease. How large that share is differs from person to person.
Area 4: your history
What may have stressed the gut- Several courses of antibiotics in recent years, with or without subsequent microbiome rebuild
- A longer phase of stress or a heavy life period. Cortisol can increase gut permeability and shift the composition of the gut flora.
- Diagnosis of “irritable bowel,” without anyone having looked for concrete causes such as SIBO, fungal overgrowth, parasites, or mold burden
- Amalgam fillings, now or earlier, or a living situation with mold infestation. Mycotoxins can burden the gut barrier and undercut a gut therapy as long as the source persists.
- Long-term PPI use (proton pump inhibitors). A lack of stomach acid can raise SIBO risk and weaken the stomach’s barrier function. Please never stop a PPI on your own, discuss it with the prescribing practice.
- A diet over a long time high in sugar, alcohol, or highly processed foods, even if it is now in the past
Area 5: time dimension and therapy history
Duration and course tell a lot- Your complaints have lasted for more than six months, with or without an official diagnosis
- You already have therapy attempts behind you that helped briefly but never took hold lastingly
- You take probiotics or follow diets, see short improvements, then everything comes back
- The investigations so far have been unremarkable, while you do not feel that way
How many points did you count?
These questions do not replace a medical history or laboratory diagnostics. They are an orientation aid, not a diagnosis. Not everyone with exhaustion has a gut problem. And not every gut problem is immediately a case for a full reset. What counts is the overall context. That is exactly what the first appointment is for.
How I work with you
Chronic gut problems are not a fate. They are a signal of a system that needs help. The right help requires time, patience, and above all an honest, complete inventory of what is going on right now.
I will not give you a standard protocol. I will listen to your story, understand it, and then develop a plan with you that is tailored to your body, your circumstances, and your goals. Sometimes the next step is simple. Sometimes it lies in a corner that no one has looked into before.
In many cases we find a way together that can change something. Sometimes a question stays open. That is part of being honest too.
Scientific sources and literature
- Cuffe et al. (2025). Network meta-analysis of dietary interventions in IBS. Lancet Gastroenterology & Hepatology.
- Wang et al. (2019). Meta-analysis: dysbiosis patterns in IBS (23 studies, n=1340). Journal of the Academy of Nutrition and Dietetics.
- Li et al. (2024). Gut microbiota meta-analysis in IBS (1167 samples). Frontiers in Microbiology.
- Erdogan & Rao (2015). Small intestinal fungal overgrowth. Current Gastroenterology Reports.
- Soliman et al. (2025). SIBO and SIFO, health implications and management. Nutrients.
- Kang & Lee (2024). DON damages tight junctions in chicken intestinal organoids. Journal of Animal Science and Biotechnology. (in vitro cell model, animal origin)
- Xu et al. (2025). Aflatoxin B1 activates NLRP3 inflammasome, disrupts tight junctions. Ecotoxicology and Environmental Safety.
- Cox et al. (2020). Low-FODMAP reduces Bifidobacterium in IBD patients. Gastroenterology. RCT, n=52, 4 weeks.
- Black et al. (2020). Psychological interventions for IBS, network meta-analysis (41 RCTs, n=4072). Gut.
- Chedid et al. (2014). Herbal therapy for small intestinal bacterial overgrowth. Global Advances in Health and Medicine. n=104, not randomized.
- Comas-Basté et al. (2020). Histamine intolerance: current state of the art. Biomolecules.
- Bravo et al. (2011). L. rhamnosus JB-1 modulates brain GABA via vagus nerve. PNAS. (in vivo animal study)
- Yin (2025). tVNS for gastrointestinal motility disorders. Journal of Translational Gastroenterology.
- Cryan et al. (2019). The microbiota-gut-brain axis. Physiological Reviews. 136-page review.
- Konijeti et al. (2017). Autoimmune protocol diet in IBD. Inflammatory Bowel Diseases. n=15, open single-arm study without control group.
- Kong et al. (2021). Ketogenic diet ameliorates colitis, microbiome analysis. Signal Transduction and Targeted Therapy.
- Huang et al. (2022). BHB ameliorates colitis, promotes M2 macrophage polarization. BMC Medicine.
- Pimentel et al. (2004). Elemental diet and breath test in SIBO. Digestive Diseases and Sciences. n=93, retrospective, without control group.
- Nathan N. (2018). Toxic: Heal Your Body from Mold, Lyme, and Other Chronic Conditions. Victory Belt Publishing.
- Fasano A. (2012). Leaky gut and autoimmune diseases. Clinical Reviews in Allergy & Immunology.
- Ignácio et al. (2024). Glyphosate and gut dysbiosis, systematic review. Food & Function.
- Gao et al. (2022). BHB upregulates Claudin-1, mitigates hyperpermeability. Frontiers in Immunology.
- Khalighi Sikaroudi et al. (2024). Low-FODMAP umbrella review (24 RCTs, n=1646). Food & Function.
- Habtemariam S. (2020). Berberine and gut microbiota, the hidden organ hypothesis. Pharmacological Research.
- Sender, Fuchs & Milo (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS Biology. DOI 10.1371/journal.pbio.1002533
- AWMF S2k guideline 161-001. Medical clinical diagnostics after indoor mold exposure (Germany).